Effects of COX-2 inhibition on expression of vascular endothelial growth factor and interleukin-8 in lung cancer cells

scientific article

Effects of COX-2 inhibition on expression of vascular endothelial growth factor and interleukin-8 in lung cancer cells is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1014984730
P356DOI10.1186/1471-2407-8-218
P932PMC publication ID2516523
P698PubMed publication ID18671849
P5875ResearchGate publication ID23142010

P50authorPenella WollQ57474508
P2093author name stringYong Ming Zhu
Danny C W Yu
Nor Saadah M Azahri
P2860cites workSurvival in small cell lung cancer is independent of tumor expression of VEGF and COX-2.Q45031019
Celecoxib inhibits angiogenesis by inducing endothelial cell apoptosis in human pancreatic tumor xenograftsQ45101669
Serum vascular endothelial growth factor (VEGF) and bcl-2 levels in advanced stage non-small cell lung cancer.Q53598685
Correlation between cyclooxygenase-2 and tumor angiogenesis in non-small cell lung cancerQ53649344
Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients.Q54681218
NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitroQ72321250
Correlation of total VEGF mRNA and protein expression with histologic type, tumor angiogenesis, patient survival and timing of relapse in non-small-cell lung cancerQ73259688
High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancerQ74534930
The intratumoral expression of vascular endothelial growth factor and interleukin-8 associated with angiogenesis in nonsmall cell lung carcinoma patientsQ77357051
Serum vascular endothelial growth factor (VEGF) and interleukin-8 (IL-8) levels in small cell lung cancerQ80184030
Human small cell lung cancer cells express functional VEGF receptors, VEGFR-2 and VEGFR-3Q80556469
Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancerQ28194900
Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancerQ28278736
Metabolism of PGE2 by prostaglandin dehydrogenase is essential for remodeling the ductus arteriosusQ28512617
Interleukin-8 and human cancer biologyQ34360704
Expression of cyclooxygenase-2 in human lung carcinomaQ34755008
Cyclooxygenase 2: a molecular target for cancer prevention and treatmentQ35057356
Cyclooxygenase as a target in lung cancerQ35817554
Mitogenic effects of interleukin-8/CXCL8 on cancer cellsQ36429600
Has Cox-2 a prognostic role in non-small-cell lung cancer? A systematic review of the literature with meta-analysis of the survival resultsQ36512153
A high vascular count and overexpression of vascular endothelial growth factor are associated with unfavourable prognosis in operated small cell lung carcinoma.Q36644123
Overexpression of cyclooxygenase-2 in non-small cell lung cancerQ38448860
Interleukin-8/CXCL8 is a growth factor for human lung cancer cellsQ38799309
Involvement of IL-8 in COX-2-mediated bone metastases from breast cancerQ40282966
Cyclooxygenase-2-dependent activation of signal transducer and activator of transcription 3 by interleukin-6 in non-small cell lung cancerQ40353025
Radiosensitivity enhancement by celecoxib, a cyclooxygenase (COX)-2 selective inhibitor, via COX-2-dependent cell cycle regulation on human cancer cells expressing differential COX-2 levelsQ40360880
Cyclooxygenase-2-dependent expression of angiogenic CXC chemokines ENA-78/CXC Ligand (CXCL) 5 and interleukin-8/CXCL8 in human non-small cell lung cancerQ40583103
Serum vascular endothelial growth factor levels correlate better with tumour stage in small cell lung cancer than albumin, neuron-specific enolase or lactate dehydrogenaseQ40643170
Elevated serum levels of interleukin-8 in advanced non-small cell lung cancer patients: relationship with prognosisQ42435391
A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2.Q43763000
Cyclooxygenase (COX) inhibitors induce apoptosis in non-small cell lung cancer through cyclooxygenase independent pathways.Q44378582
Interleukin-8 messenger ribonucleic acid expression correlates with tumor progression, tumor angiogenesis, patient survival, and timing of relapse in non-small-cell lung cancer.Q44984368
P407language of work or nameEnglishQ1860
P921main subjectlung cancerQ47912
endotheliumQ111140
P304page(s)218
P577publication date2008-07-31
P1433published inBMC CancerQ326300
P1476titleEffects of COX-2 inhibition on expression of vascular endothelial growth factor and interleukin-8 in lung cancer cells
P478volume8

Reverse relations

cites work (P2860)
Q38288739A stratified randomized double-blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study.
Q34290118Apricoxib, a novel inhibitor of COX-2, markedly improves standard therapy response in molecularly defined models of pancreatic cancer
Q37727431Chitosan oligosaccharides suppress LPS-induced IL-8 expression in human umbilical vein endothelial cells through blockade of p38 and Akt protein kinases
Q36883777Co-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cells
Q35928999Combination of metformin and 5-aminosalicylic acid cooperates to decrease proliferation and induce apoptosis in colorectal cancer cell lines
Q64059711Cyclooxygenase-2 Activity Regulates Recruitment of VEGF-Secreting Ly6C Monocytes in Ventilator-Induced Lung Injury
Q35645052Cyclooxygenase-2-expressing macrophages in human pterygium co-express vascular endothelial growth factor
Q38794384Dual Stimuli-Responsive Nanoparticles for Controlled Release of Anticancer and Anti-inflammatory Drugs Combination
Q26824679Effects of intermittent fasting on metabolism in men
Q39406853Effects of the inhibition of cytosolic phospholipase A(2)α in non-small cell lung cancer cells.
Q36363166Growth and adherence of Staphylococcus aureus were enhanced through the PGE2 produced by the activated COX-2/PGE2 pathway of infected oral epithelial cells
Q53479155Interleukin-8-producing primary cardiac undifferentiated sarcoma in a child with sustained fever.
Q38053088Involvement of β-arrestins in cancer progression
Q90384113Mapping the structure and biological functions within mesenchymal bodies using microfluidics
Q36903409New use for an old drug: COX-independent anti-inflammatory effects of sulindac in models of cystic fibrosis.
Q33794119Prostaglandin E2 promotes lung cancer cell migration via EP4-betaArrestin1-c-Src signalsome.
Q35892555The COX-2-Selective Antagonist (NS-398) Inhibits Choroidal Neovascularization and Subretinal Fibrosis

Search more.